Combine CHILD and Domestic Violence Fatality Reviews
LA County Child and Domestic Violence Fatality Review share common members and shared cases including multiple children killed by the fathers when their wives said they were leaving. There are differences DVFR delays review to wait for courts to finish. Child Fatality Review likes to get cases ASAP. We will avoid this difference with joint review of familial child homicide and homicide/suicide with no court action,
We will begin with local contacts for teams working together and find others to join us. We will build a model in LA County and poll other teams for additional models. By the APHA meeting we will 1) finish a poll on teams that have met together 2) Add poll information to to draft protocols. 3) Share draft protocols with ICAN/NCFR and DVFR contacts. Include models for grief support for survivors.
The APHA presentation will address.
1) Gathering child and adult multiagency teams to work together
2) Using teams as peer support in building more
3) Protocols for Fatal Family Violence Review
Learning Areas:Communication and informatics
Ethics, professional and legal requirements
Other professions or practice related to public health
Public health or related laws, regulations, standards, or guidelines
Social and behavioral sciences
Systems thinking models (conceptual and theoretical models), applications related to public health
Describe the basic process of fatal family violence List the three benefits of combining fatal child and domestic violence fatality review Describe the history of child fatality review
Keyword(s): Family Involvement, Violence & Injury Prevention
Qualified on the content I am responsible for because: I have 40 years working with child abuse and 37 with fatal child abuse and 30 plus iwht fatal domestic violence and consultation with most states and multiple nations.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.